The conference presentation schedule is as follows:
Credit Suisse 2010 Healthcare Conference | |
November 12, 2010 at 9:30 a.m. MST | |
Arizona Biltmore Hotel, Phoenix, AZ | |
Lazard Capital Markets 7th Annual Healthcare Conference | |
November 16, 2010 at 3:10 p.m. EST | |
St. Regis Hotel, New York, NY | |
A live audio webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development is QNEXA®, which also is in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.
CONTACT: | |||
VIVUS, Inc. | Investor Relations: | The Trout Group | |
Timothy E. Morris | Brian Korb | ||
Chief Financial Officer | bkorb@troutgroup.com | ||
650-934-5200 | 646-378-2923 | ||
SOURCE VIVUS, Inc.
